The m6A methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..

Mitochondrial biogenesis and energy metabolism are essential for regulating the inflammatory state of monocytes. This state is partially controlled by peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a coactivator that regulates mitochondrial biogenesis and energy metabolism. Disruption of these processes can also contribute to the initiation of chronic inflammatory diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis. Methyltransferase-like 3 (METTL3)-dependent N6-methyladenosine (m6A) methylation has recently been shown to regulate a variety of inflammatory processes. However, the role of m6A mRNA methylation in affecting mitochondrial metabolism in monocytes under inflammation is unclear, nor is there an established relationship between m6A methylation and PGC-1α. In this study, we identified a novel mechanism by which METTL3 acts during oxidized low-density lipoprotein (oxLDL)-induced monocyte inflammation, where METTL3 and YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) cooperatively modify PGC-1α mRNA, mediating its degradation, decreasing PGC-1α protein levels, and thereby enhancing the inflammatory response. METTL3 coordinated with YTHDF2 to suppress the expression of PGC-1α, as well as that of cytochrome c (CYCS) and NADH:ubiquinone oxidoreductase subunit C2 (NDUFC2) and reduced ATP production and oxygen consumption rate (OCR). This subsequently increased the accumulation of cellular and mitochondrial reactive oxygen species (ROS) and the levels of proinflammatory cytokines in inflammatory monocytes. These data may provide new insights into the role of METTL3-dependent m6A modification of PGC-1α mRNA in the monocyte inflammation response. These data also contribute to a more comprehensive understanding of the pathogenesis of monocyte-macrophage inflammation-associated diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:297

Enthalten in:

The Journal of biological chemistry - 297(2021), 3 vom: 15. Sept., Seite 101058

Sprache:

Englisch

Beteiligte Personen:

Zhang, Xinning [VerfasserIn]
Li, Xin [VerfasserIn]
Jia, Hongti [VerfasserIn]
An, Guoshun [VerfasserIn]
Ni, Juhua [VerfasserIn]

Links:

Volltext

Themen:

EC 2.1.1.-
EC 2.1.1.62
EC 7.1.1.2
Electron Transport Complex I
Inflammation
Journal Article
Lipoproteins, LDL
M(6)A modification
METTL3
METTL3 protein, human
Methyltransferases
Mitochondria
Monocytes
NDUFC2 protein, human
Oxidized low density lipoprotein
PGC-1α
PPARGC1A protein, human
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
Post-transcriptional regulation
RNA, Messenger
RNA methylation
RNA-Binding Proteins
Reactive Oxygen Species
Research Support, Non-U.S. Gov't
YTHDF2 protein, human

Anmerkungen:

Date Completed 08.12.2021

Date Revised 14.12.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jbc.2021.101058

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32919660X